Related Experiment Video
Updated: Mar 21, 2026
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete
Rutika R Naik1, Nilesh L Gardi1, Sharmila A Bapat1
1National Centre for Cell Science, NCCS Complex, Pune 411007, INDIA.
Abstract:
Intratumor heterogeneity presents a major hurdle in cancer therapy. Most current research studies consider tumors as single entities and overlook molecular diversity between heterogeneous state(s) of different cells assumed to be homogenous. The present approach was designed for fluorescence-activated cell sorting-based resolution of heterogeneity arising from cancer stem cell (CSC) hierarchies and genetic instability in ovarian tumors, followed by microarray-based expression profiling of sorted fractions. Through weighted gene correlation network analyses, we could assign enriched modules of co-regulated genes to each fraction. Such gene modules often correlate with biological functions; one such specific association was the enrichment of CD53 expression in CSCs, functional validation indicated CD53 to be a tumor-initiating cell- rather than quiescent CSC-marker. Another association defined a state of poise for stress-induced metastases in aneuploid cells. Our results thus emphasize the need for studying cell-specific functionalities relevant to regeneration, drug resistance and disease progression in discrete tumor cell fractions.
Insights
Understanding ovarian tumor heterogeneity is key to effective cancer therapy. This study resolves cellular diversity, identifying CD53 as a tumor-initiating cell marker and revealing aneuploid cell states linked to metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Intratumor heterogeneity complicates cancer therapy by masking molecular diversity within tumors.
- Current research often treats tumors as uniform entities, neglecting cellular heterogeneity.
Purpose of the Study:
- To resolve heterogeneity in ovarian tumors using fluorescence-activated cell sorting and expression profiling.
- To identify distinct cell populations and their associated molecular functions.
Main Methods:
- Fluorescence-activated cell sorting (FACS) to isolate distinct cell fractions from ovarian tumors.
- Microarray-based expression profiling of sorted cell populations.
- Weighted gene correlation network analyses (WGCNA) to identify co-regulated gene modules.
Main Results:
- Identified distinct gene modules enriched in specific cell fractions.
- Validated CD53 as a marker for tumor-initiating cells, not quiescent cancer stem cells (CSCs).
- Revealed aneuploid cell states poised for stress-induced metastasis.
Conclusions:
- Studying discrete tumor cell fractions is crucial for understanding cell-specific functions in cancer.
- Findings highlight the need to address heterogeneity for improved cancer regeneration, drug resistance, and disease progression strategies.
- CD53 and aneuploid cell states represent key targets for therapeutic intervention.
